Astellas and Fujitsu Sign Agreement for Information-System Outsourcing
Tokyo, October 28, 2005 — Astellas Pharma Inc. (“Astellas”) and Fujitsu Limited (“Fujitsu”) today announced that they have reached an information-system outsourcing agreement on October 28. Under the agreement, the operation of Astellas’ information systems which has been handled by Astellas Systems Co.,Ltd. (a wholly owned subsidiary of Astellas, “Astellas Systems”) and its headquarter ERP systems will be outsourced to Fujitsu.
Under this agreement, Fujitsu will take in Astellas Systems’ know-how in pharmaceutical-related information systems, which Fujitsu intends to leverage in expanding its business with pharmaceutical companies.
While, Astellas will leverage Fujitsu’s considerable experience and the existing outsourcing structure, which has been formed at Astellas, to realize a higher-quality and more efficient systems operation.
Following this agreement, Astellas Systems is to be dissolved at the end of March 2006.
About Astellas Pharma Inc.
Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. In April 2005, the company was formed through the merger of Fujisawa Pharmaceutical Co., Ltd. and Yamanouchi Pharmaceutical Co., Ltd. The organization is committed to becoming a global mega pharmaceutical company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. For more information on Astellas Pharma Inc., please visit the company’s website at www.astellas.com.
Fujitsu is a leading provider of customer-focused IT and communications solutions for the global marketplace. Pace-setting device technologies, highly reliable computing and communications products, and a worldwide corps of systems and services experts uniquely position Fujitsu to deliver comprehensive solutions that open up infinite possibilities for its customers’ success. Headquartered in Tokyo, Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.7 trillion yen (US$44.5 billion) for the fiscal year ended March 31, 2005. For more information, please see www.fujitsu.com
- Contact Information
- Corporate Communications
- Astellas Pharma Inc.
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.